PAVONI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 742
EU - Europa 526
AS - Asia 187
AF - Africa 21
SA - Sud America 12
Totale 1.488
Nazione #
US - Stati Uniti d'America 741
IT - Italia 129
SE - Svezia 115
GB - Regno Unito 77
DE - Germania 75
VN - Vietnam 72
IN - India 40
IE - Irlanda 39
CN - Cina 34
FR - Francia 21
JO - Giordania 19
RU - Federazione Russa 15
BG - Bulgaria 11
SG - Singapore 11
FI - Finlandia 9
BR - Brasile 8
TG - Togo 7
CH - Svizzera 6
CI - Costa d'Avorio 6
ZA - Sudafrica 6
BE - Belgio 4
EE - Estonia 4
GR - Grecia 4
UA - Ucraina 4
AL - Albania 3
AT - Austria 3
PT - Portogallo 3
KZ - Kazakistan 2
PE - Perù 2
TR - Turchia 2
TW - Taiwan 2
AR - Argentina 1
CA - Canada 1
CL - Cile 1
ES - Italia 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
MM - Myanmar 1
NG - Nigeria 1
NL - Olanda 1
PL - Polonia 1
RO - Romania 1
SN - Senegal 1
UZ - Uzbekistan 1
Totale 1.488
Città #
Chandler 114
Dong Ket 72
Southend 71
Fairfield 69
Ashburn 47
Woodbridge 40
Dublin 39
Wilmington 37
Princeton 36
Bologna 28
Redmond 28
Seattle 27
Houston 25
Cambridge 22
Amman 19
New York 18
Turin 16
Ann Arbor 11
Faenza 11
Sofia 11
Berlin 10
Tappahannock 10
Des Moines 9
Westminster 8
Helsinki 7
Lomé 7
Singapore 7
Abidjan 6
Aracaju 5
Asnieres-sur-Seine 5
San Diego 5
Bern 4
Brussels 4
Jinan 4
Milan 4
Seriate 4
Boydton 3
Guangzhou 3
Hyderabad 3
Medolla 3
Rome 3
Shenyang 3
Almaty 2
Athens 2
Bari 2
Bocholt 2
Boffalora d'Adda 2
Bremen 2
Clearwater 2
Columbus 2
Dearborn 2
Florence 2
Genova 2
Grottammare 2
Hebei 2
Hwang Chow 2
Kaohsiung City 2
Lappeenranta 2
Los Angeles 2
Medford 2
Modena 2
Mogliano 2
Nanchang 2
Nanjing 2
Napoli 2
Novara 2
Porto 2
Potenza 2
Redwood City 2
São Paulo 2
Taiyuan 2
Zhengzhou 2
Abeokuta 1
Amsterdam 1
Baotou 1
Beijing 1
Benevento 1
Budrio 1
Buscate 1
Bühl 1
Cacem 1
Calvizzano 1
Chengdu 1
Chicago 1
Chiswick 1
Cupertino 1
Düsseldorf 1
Falls Church 1
Ferrara 1
Haifa 1
Hangzhou 1
Imola 1
Istanbul 1
Kemerovo 1
Kunming 1
Lanzhou 1
Le Pré-saint-gervais 1
London 1
Lucknow 1
Maranello 1
Totale 946
Nome #
Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016 136
Antimicrobial Efficacy of Five Probiotic Strains Against Helicobacter Pylori 110
Antibiotic resistance and therapy outcome in H. pylori eradication failure patients. 109
Antibiotic resistance and therapy for H. pylori infection in immigrant patients managed in Italy 107
Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19 97
Efficacy of a New Nutraceutical Formulation in Patients with Symptomatic Uncomplicated Diverticular Disease (SUDD): a Prospective Observational Study 90
Antifungal Activity of Natural Compounds vs. Candida spp.: A Mixture of Cinnamaldehyde and Eugenol Shows Promising In Vitro Results 87
Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication 86
null 81
Pylera and sequential therapy for first-line Helicobacter pylori eradication: A culture-based study in real clinical practice 68
Trends in Primary Antibiotic Resistance in H. pylori Strains Isolated in Italy between 2009 and 2019 66
Rescue therapies for H. pylori infection in foreign patients treated in Italy. 62
Upper Endoscopy in Patients with Extra-Oesophageal Reflux Symptoms: A Multicentre Study 58
Rifabutin-Based Triple Therapy Or Bismuth-Based Quadruple Regimen As Rescue Therapies For Helicobacter pylori Infection 56
Efficacy of a new nutraceutical formulation (CHETOGERD®) in patients with nonerosive reflux (NERD): a prospective observational study. 56
Next Generation Sequencing for the Prediction of the Antibiotic Resistance in Helicobacter pylori: A Literature Review 52
Feasibility and effectiveness assessment of sars-cov-2 antigenic tests in mass screening of a pediatric population and correlation with the kinetics of viral loads 45
Rescue Therapies for Helicobacter pylori Infection in Foreign Patients Treated in Italy 40
Culture-based antibiotic susceptibility testing for Helicobacter pylori infection: a systematic review 27
Rescue Therapies for H. pylori Infection in Italy 27
Effectiveness of first and second-line empirical treatment in Italy: Results of the European registry on Helicobacter pylori management. 22
Antimicrobial Resistance of Genital Mycoplasma and Ureaplasma: A Multicentre Study Over a 5-Year Period in Italy (2017-2021) 15
First-line therapies for H. pylori infection in Italy: a pooled-data analysis 14
Efficacy of a new nutraceutical formulation: L-tryptophan, probiotics, charcoal, chamomile, mint, and licorice (COLONIR®) in the improvement of gastrointestinal symptoms in subjects with irritable bowel syndrome 13
Culture-based antibiotic susceptibility testing for Helicobacter pylori infection: a systematic review 11
Respiratory Syncytial Virus-Load Kinetics and Clinical Course of Acute Bronchiolitis in Hospitalized Infants: Interim Results and Review of the Literature 9
Inherited Chromosomally Integrated Human Herpesvirus 6: Laboratory and Clinical Features. 8
Efficacy of a new nutraceutical formulation: L-tryptophan, probiotics, charcoal, chamomile, mint, and licorice (COLONIR®) in the improvement of gastrointestinal symptoms in subjects with irritable bowel syndrome 7
Analysis of Clinical Phenotypes through Machine Learning of First-Line H. pylori Treatment in Europe during the Period 2013–2022: Data from the European Registry on H. pylori Management (Hp-EuReg) 5
First-line therapies for H. pylori infection in Italy: a pooled-data analysis 5
Totale 1.569
Categoria #
all - tutte 5.565
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.565


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020172 20 4 0 5 14 14 26 29 28 13 11 8
2020/2021245 33 8 15 2 9 1 17 9 29 15 8 99
2021/2022375 10 8 20 39 27 12 17 38 15 27 105 57
2022/2023484 30 51 22 59 34 46 18 39 87 32 37 29
2023/2024240 17 53 20 33 13 37 7 11 7 16 20 6
2024/202524 24 0 0 0 0 0 0 0 0 0 0 0
Totale 1.569